Dawid Leksa
Dawid Leksa has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- David Aebisher
Department of Photomedicine and Physical Chemistry, Faculty of Medicine, University of Rzeszów, 35-310 Rzeszów, Poland
9 shared publications - Dorota Bartusik-Aebisher
Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszow, 35-310 Rzeszów, Poland
9 shared publications - Angelika Myśliwiec
Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland
6 shared publications - Adrian Truszkiewicz
Department of Photomedicine and Physical Chemistry, Medical College, The Rzeszów University, 35-310 Rzeszów, Poland
5 shared publications - Wiktoria Mytych
English Division Science Club, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszów, Poland
5 shared publications - Klaudia Dynarowicz
Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszow, 35-310 Rzeszów, Poland
4 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8745
Molecular Mapping of Atherosclerotic Plaques with MALDI Mass Spectrometry Imaging
Atherosclerosis develops within heterogeneous arterial plaques. Here, even closely neighbouring regions can differ substantially in biological activity and potential vulnerability to rupture and thrombosis. Through matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) and especially MALDI imaging, these differences within the plaque can be studied while also preserving tissue architecture. With MALDI analysis, prepared tissue sections are converted into spatial molecular maps that show the differences in plaque chemistry across the arterial wall. These maps can be used to link changes in lipids and other biomolecules to regions affected by inflammation, necrosis, calcification and thrombosis. This narrative review, supported by a structured search of PubMed and PubMed Central from database inception to 14 September 2026, critically examines MALDI-based research in atherosclerosis across a translational continuum. The evidence base centres on spatial MALDI-MSI of plaque tissue, with non-imaging MALDI and orthogonal non-MALDI studies used as complementary context. Particular attention is given to the strength of evidence supporting proposed molecular signatures and to the distinction between exploratory findings and clinically validated applications. Integration of MALDI with histology, clinical imaging and emerging spatial-omics approaches could strengthen the biological interpretation of plaque-specific molecular signatures. However, methodological heterogeneity, incomplete molecular identification, small study populations and limited independent and prospective validation currently restrict translation into clinical practice.
- 30 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8745
Open AccessMolecular Mapping of Atherosclerotic Plaques with MALDI Mass Spectrometry Imaging
Atherosclerosis develops within heterogeneous arterial plaques. Here, even closely neighbouring regions can differ substantially in biological activity and potential vulnerability to rupture and thrombosis. Through matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) and especially MALDI imaging, these differences within the plaque can be studied while also preserving tissue architecture. With MALDI analysis, prepared tissue sections are converted into spatial molecular maps that show the differences in plaque chemistry across the arterial wall. These maps can be used to link changes in lipids and other biomolecules to regions affected by inflammation, necrosis, calcification and thrombosis. This narrative review, supported by a structured search of PubMed and PubMed Central from database inception to 14 September 2026, critically examines MALDI-based research in atherosclerosis across a translational continuum. The evidence base centres on spatial MALDI-MSI of plaque tissue, with non-imaging MALDI and orthogonal non-MALDI studies used as complementary context. Particular attention is given to the strength of evidence supporting proposed molecular signatures and to the distinction between exploratory findings and clinically validated applications. Integration of MALDI with histology, clinical imaging and emerging spatial-omics approaches could strengthen the biological interpretation of plaque-specific molecular signatures. However, methodological heterogeneity, incomplete molecular identification, small study populations and limited independent and prospective validation currently restrict translation into clinical practice.
- Open Access
- 3 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3507
Atherosclerotic Plaque Characterization Magnetic Resonance Imaging In Vitro at 1.5 Tesla for the Assessment of Coronary Artery Disease
Background/Objectives: The composition of atherosclerotic plaques is increasingly recognized as a key factor determining cardiovascular risk. Features such as intraplaque hemorrhage, a necrotic lipid core, and the integrity of the fibrous cap are strongly associated with plaque instability and the occurrence of adverse clinical events. Magnetic resonance imaging (MRI) allows for non-invasive characterization of plaque microstructure through quantitative mapping of T1 and T2 relaxation times; however, image noise may limit the accuracy of these measurements. Methods: In this experimental study, a total of 15 ex vivo atherosclerotic plaque samples were imaged using a 1.5T scanner with a fast spin-echo sequence featuring variable repetition times (TR: 200–12,000 ms) and echo times (TE: 21–240 ms) to obtain T1 and T2 maps. An Attention–Residual–Dense U-Net neural network was trained on pairs of noisy and reference images to reduce Rician noise while preserving structural details. Results: The 15 samples examined exhibited T1 values ranging from 1768 to 3294 ms and T2 values ranging from 138 to 202 ms, which were shorter than those for water (T1: 3323 ms; T2: 114 ms), which is consistent with the presence of collagen, lipids, and mineral deposits. Variability among samples reflected differences in composition, with the shortest relaxation times suggesting advanced calcifications. The application of deep learning methods allowed for a threefold improvement in the signal-to-noise ratio (SNR) while preserving the microarchitecture of the lamina. Conclusions: Quantitative T1/T2 mapping combined with deep learning-based image enhancement methods constitutes a robust tool for high-resolution characterization of atherosclerotic plaque composition under ex vivo conditions. The results obtained indicate the potential for translating this method to in vivo studies to better detect tissue heterogeneity and features associated with plaque instability.
- 3 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3507
Open AccessAtherosclerotic Plaque Characterization Magnetic Resonance Imaging In Vitro at 1.5 Tesla for the Assessment of Coronary Artery Disease
Background/Objectives: The composition of atherosclerotic plaques is increasingly recognized as a key factor determining cardiovascular risk. Features such as intraplaque hemorrhage, a necrotic lipid core, and the integrity of the fibrous cap are strongly associated with plaque instability and the occurrence of adverse clinical events. Magnetic resonance imaging (MRI) allows for non-invasive characterization of plaque microstructure through quantitative mapping of T1 and T2 relaxation times; however, image noise may limit the accuracy of these measurements. Methods: In this experimental study, a total of 15 ex vivo atherosclerotic plaque samples were imaged using a 1.5T scanner with a fast spin-echo sequence featuring variable repetition times (TR: 200–12,000 ms) and echo times (TE: 21–240 ms) to obtain T1 and T2 maps. An Attention–Residual–Dense U-Net neural network was trained on pairs of noisy and reference images to reduce Rician noise while preserving structural details. Results: The 15 samples examined exhibited T1 values ranging from 1768 to 3294 ms and T2 values ranging from 138 to 202 ms, which were shorter than those for water (T1: 3323 ms; T2: 114 ms), which is consistent with the presence of collagen, lipids, and mineral deposits. Variability among samples reflected differences in composition, with the shortest relaxation times suggesting advanced calcifications. The application of deep learning methods allowed for a threefold improvement in the signal-to-noise ratio (SNR) while preserving the microarchitecture of the lamina. Conclusions: Quantitative T1/T2 mapping combined with deep learning-based image enhancement methods constitutes a robust tool for high-resolution characterization of atherosclerotic plaque composition under ex vivo conditions. The results obtained indicate the potential for translating this method to in vivo studies to better detect tissue heterogeneity and features associated with plaque instability.
- Open Access
- 23 February 2026
- Published by MDPI AG in Journal of the Oman Medical Association
- Vol. 3 (1) , 3
Potential of Photodynamic Therapy in Children and Adolescents with Central Nervous System Tumors
Central nervous system (CNS) tumors in children, though uncommon, pose distinct challenges due to their unique pathological and clinical features, which often differ from adult cases. Effective management of pediatric CNS tumors can be complicated, with complete surgical resection remaining a critical goal, in conditions like cerebra cavernous malformation (CCM), where it significantly impacts recurrence risk. However, achieving complete resection can be difficult, as preserving the surrounding healthy tissue is vital to avoid long-term neurological deficits, a particular concern in the developing brains of children. Photodynamic therapy (PDT) has emerged as a promising adjunctive treatment for pediatric CNS tumors due to its ability to selectively target tumor cells while sparing healthy tissue. PDT uses a photosensitizing agent. This targeted approach is advantageous in pediatric cases as it minimizes collateral damage, potentially reducing the long-term neurological and cognitive impacts seen with conventional treatments such as radiation. Despite its promise, the application of PDT for pediatric CNS tumors remains underexplored. Research is limited, primarily due to the rarity of these tumors in children and the ethical challenges involved in conducting pediatric trials. The current understanding of PDT’s effectiveness in CNS tumors largely stems from adult studies, which may not fully apply to children’s unique developmental and physiological characteristics, including differences in the tumor biology, metabolism, and pharmacokinetics of photosensitizers. To address this gap, our study conducted a comprehensive review of the available literature using PubMed, Google Scholar, and additional databases like Web of Science, aiming to summarize the existing knowledge on PDT for pediatric CNS tumors, incorporate recent advancements from the last years, and identify areas where further research is essential. The updated review includes new insights from ongoing sonodynamic therapy (SDT), which complements PDT by using ultrasound to enable deeper penetration.
- 23 February 2026
- Published by MDPI AG in Journal of the Oman Medical Association
- Vol. 3 (1) , 3
Open AccessPotential of Photodynamic Therapy in Children and Adolescents with Central Nervous System Tumors
Central nervous system (CNS) tumors in children, though uncommon, pose distinct challenges due to their unique pathological and clinical features, which often differ from adult cases. Effective management of pediatric CNS tumors can be complicated, with complete surgical resection remaining a critical goal, in conditions like cerebra cavernous malformation (CCM), where it significantly impacts recurrence risk. However, achieving complete resection can be difficult, as preserving the surrounding healthy tissue is vital to avoid long-term neurological deficits, a particular concern in the developing brains of children. Photodynamic therapy (PDT) has emerged as a promising adjunctive treatment for pediatric CNS tumors due to its ability to selectively target tumor cells while sparing healthy tissue. PDT uses a photosensitizing agent. This targeted approach is advantageous in pediatric cases as it minimizes collateral damage, potentially reducing the long-term neurological and cognitive impacts seen with conventional treatments such as radiation. Despite its promise, the application of PDT for pediatric CNS tumors remains underexplored. Research is limited, primarily due to the rarity of these tumors in children and the ethical challenges involved in conducting pediatric trials. The current understanding of PDT’s effectiveness in CNS tumors largely stems from adult studies, which may not fully apply to children’s unique developmental and physiological characteristics, including differences in the tumor biology, metabolism, and pharmacokinetics of photosensitizers. To address this gap, our study conducted a comprehensive review of the available literature using PubMed, Google Scholar, and additional databases like Web of Science, aiming to summarize the existing knowledge on PDT for pediatric CNS tumors, incorporate recent advancements from the last years, and identify areas where further research is essential. The updated review includes new insights from ongoing sonodynamic therapy (SDT), which complements PDT by using ultrasound to enable deeper penetration.
- Open Access
- 9 February 2026
- Published by AccScience Publishing in Brain & Heart
- Vol. 4 (2) , 025170021
Comparative effects of endarterectomy and balloon angioplasty with stent implantation on carotid artery flow velocity in carotid artery stenosis
Hemodynamically significant carotid artery stenosis is a major, modifiable contributor to ischemic stroke/transient ischemic attack (TIA), and both carotid endarterectomy (CEA) and carotid artery stenting (CAS) are established revascularization strategies aimed at restoring cerebral perfusion and normalizing carotid flow hemodynamics. This prospective study compared the outcomes of CEA and CAS with balloon angioplasty and stent implantation in patients with hemodynamically significant internal carotid artery stenosis. The goal was to assess the effectiveness of the techniques in reducing peak systolic velocity and improving quality of life. Between March 2019 and December 2020, 106 patients (47% male, 53% female; aged 40–75 years) were enrolled at the Rzeszów Center for Vascular and Endovascular Surgery, Poland. Inclusion criteria encompassed symptomatic stenosis ≥70% or selected 50–69%, as well as asymptomatic cases meeting clinical indications (e.g., prior stroke/TIA, plaque morphology, anatomy, comorbidities). Patients were assigned to the CEA or CAS group based on multidisciplinary evaluation; exclusions included lack of consent or surgical contraindications. All patients received perioperative antiplatelet therapy and statins. Evaluations included duplex ultrasound to measure peak systolic velocity and stenosis degree before the procedure and at 1 month post-intervention, along with quality-of-life questionnaires. Data were analyzed using Student’s t-tests. Preoperative peak systolic velocities differed between groups, with overall higher values in CAS and gender-specific variations (men: 363.21 cm/s in CEA vs. 345 cm/s in CAS; women: 338.97 cm/s in CEA vs. 354.96 cm/s in CAS). Both interventions led to statistically significant postoperative reductions in blood flow velocity. Postoperative hemodynamic improvements and quality-of-life outcomes were comparable between groups, with similar comorbidity impacts observed. These results indicate that CEA and CAS offer equivalent short-term effectiveness in managing carotid artery disease and reducing stroke/TIA risk.
- 9 February 2026
- Published by AccScience Publishing in Brain & Heart
- Vol. 4 (2) , 025170021
Open AccessComparative effects of endarterectomy and balloon angioplasty with stent implantation on carotid artery flow velocity in carotid artery stenosis
Hemodynamically significant carotid artery stenosis is a major, modifiable contributor to ischemic stroke/transient ischemic attack (TIA), and both carotid endarterectomy (CEA) and carotid artery stenting (CAS) are established revascularization strategies aimed at restoring cerebral perfusion and normalizing carotid flow hemodynamics. This prospective study compared the outcomes of CEA and CAS with balloon angioplasty and stent implantation in patients with hemodynamically significant internal carotid artery stenosis. The goal was to assess the effectiveness of the techniques in reducing peak systolic velocity and improving quality of life. Between March 2019 and December 2020, 106 patients (47% male, 53% female; aged 40–75 years) were enrolled at the Rzeszów Center for Vascular and Endovascular Surgery, Poland. Inclusion criteria encompassed symptomatic stenosis ≥70% or selected 50–69%, as well as asymptomatic cases meeting clinical indications (e.g., prior stroke/TIA, plaque morphology, anatomy, comorbidities). Patients were assigned to the CEA or CAS group based on multidisciplinary evaluation; exclusions included lack of consent or surgical contraindications. All patients received perioperative antiplatelet therapy and statins. Evaluations included duplex ultrasound to measure peak systolic velocity and stenosis degree before the procedure and at 1 month post-intervention, along with quality-of-life questionnaires. Data were analyzed using Student’s t-tests. Preoperative peak systolic velocities differed between groups, with overall higher values in CAS and gender-specific variations (men: 363.21 cm/s in CEA vs. 345 cm/s in CAS; women: 338.97 cm/s in CEA vs. 354.96 cm/s in CAS). Both interventions led to statistically significant postoperative reductions in blood flow velocity. Postoperative hemodynamic improvements and quality-of-life outcomes were comparable between groups, with similar comorbidity impacts observed. These results indicate that CEA and CAS offer equivalent short-term effectiveness in managing carotid artery disease and reducing stroke/TIA risk.
- Open Access
Identification of Cholesterol in Plaques of Atherosclerotic Using Magnetic Resonance Spectroscopy and 1D U-Net Architecture
Cholesterol plays a fundamental role in the human body—it stabilizes cell membranes, modulates gene expression, and is a precursor to steroid hormones, vitamin D, and bile salts. Its correct level is crucial for homeostasis, while both excess and deficiency are associated with serious metabolic and health consequences. Excessive accumulation of cholesterol leads to the development of atherosclerosis, while its deficiency disrupts the transport of fat-soluble vitamins. Magnetic resonance spectroscopy (MRS) enables the detection of cholesterol esters and the differentiation between their liquid and crystalline phases, but the technical limitations of clinical MRI systems require the use of dedicated coils and sequence modifications. This study demonstrates the feasibility of using MRS to identify cholesterol-specific spectral signatures in atherosclerotic plaque through ex vivo analysis. Using a custom-designed experimental coil adapted for small-volume samples, we successfully detected characteristic cholesterol peaks from plaque material dissolved in chloroform, with spectral signatures corresponding to established NMR databases. To further enhance spectral quality, a deep-learning denoising framework based on a 1D U-Net architecture was implemented, enabling the recovery of low-intensity cholesterol peaks that would otherwise be obscured by noise. The trained U-Net was applied to experimental MRS data from atherosclerotic plaques, where it significantly outperformed traditional denoising methods (Gaussian, Savitzky–Golay, wavelet, median) across six quantitative metrics (SNR, PSNR, SSIM, RMSE, MAE, correlation), enhancing low-amplitude cholesteryl ester detection. This approach substantially improved signal clarity and the interpretability of cholesterol-related resonances, supporting more accurate downstream spectral assessment. The integration of MRS with NMR-based lipidomic analysis, which allows the identification of lipid signatures associated with plaque progression and destabilization, is becoming increasingly important. At the same time, the development of high-resolution techniques such as μOCT provides evidence for the presence of cholesterol crystals and their potential involvement in the destabilization of atherosclerotic lesions. In summary, nanotechnology-assisted MRI has the potential to become an advanced tool in the proof-of-concept of atherosclerosis, enabling not only the identification of cholesterol and its derivatives, but also the monitoring of treatment efficacy. However, further clinical studies are necessary to confirm the practical usefulness of these solutions and their prognostic value in assessing cardiovascular risk.
Open AccessIdentification of Cholesterol in Plaques of Atherosclerotic Using Magnetic Resonance Spectroscopy and 1D U-Net Architecture
Cholesterol plays a fundamental role in the human body—it stabilizes cell membranes, modulates gene expression, and is a precursor to steroid hormones, vitamin D, and bile salts. Its correct level is crucial for homeostasis, while both excess and deficiency are associated with serious metabolic and health consequences. Excessive accumulation of cholesterol leads to the development of atherosclerosis, while its deficiency disrupts the transport of fat-soluble vitamins. Magnetic resonance spectroscopy (MRS) enables the detection of cholesterol esters and the differentiation between their liquid and crystalline phases, but the technical limitations of clinical MRI systems require the use of dedicated coils and sequence modifications. This study demonstrates the feasibility of using MRS to identify cholesterol-specific spectral signatures in atherosclerotic plaque through ex vivo analysis. Using a custom-designed experimental coil adapted for small-volume samples, we successfully detected characteristic cholesterol peaks from plaque material dissolved in chloroform, with spectral signatures corresponding to established NMR databases. To further enhance spectral quality, a deep-learning denoising framework based on a 1D U-Net architecture was implemented, enabling the recovery of low-intensity cholesterol peaks that would otherwise be obscured by noise. The trained U-Net was applied to experimental MRS data from atherosclerotic plaques, where it significantly outperformed traditional denoising methods (Gaussian, Savitzky–Golay, wavelet, median) across six quantitative metrics (SNR, PSNR, SSIM, RMSE, MAE, correlation), enhancing low-amplitude cholesteryl ester detection. This approach substantially improved signal clarity and the interpretability of cholesterol-related resonances, supporting more accurate downstream spectral assessment. The integration of MRS with NMR-based lipidomic analysis, which allows the identification of lipid signatures associated with plaque progression and destabilization, is becoming increasingly important. At the same time, the development of high-resolution techniques such as μOCT provides evidence for the presence of cholesterol crystals and their potential involvement in the destabilization of atherosclerotic lesions. In summary, nanotechnology-assisted MRI has the potential to become an advanced tool in the proof-of-concept of atherosclerosis, enabling not only the identification of cholesterol and its derivatives, but also the monitoring of treatment efficacy. However, further clinical studies are necessary to confirm the practical usefulness of these solutions and their prognostic value in assessing cardiovascular risk.
- Open Access
- 25 July 2025
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 5 (3) , 32
Magnetic Resonance Imaging Evaluation of Photodynamic Therapy with Indocyanine Green in Atherosclerosis Plaques Before and After Gadovist Administration
Background: Singlet oxygen (1O2) generation in biological samples remains a significant challenge. Studying the mechanism of 1O2 action during photodynamic therapy (PDT) in atherosclerotic plaques in vitro represents an innovative cardiological approach. Atherosclerosis, a chronic and progressive disease, is characterized by plaque buildup inside arterial walls. Objectives: This study focused on the use of spin–lattice (T1) and spin–spin (T2) relaxation times measured by Magnetic Resonance Imaging (MRI) before and after the administration of indocyanine green-mediated PDT (ICG-PDT). Methods: To enhance visualization of morphological changes in atherosclerotic plaques, the clinically approved MRI contrast agent Gadovist was utilized. A total of 12 atherosclerotic plaque samples were collected from six patients undergoing endarterectomy. The generation of 1O2 in these plaques was assessed using quantitative MRI measurements and microscopic imaging, which visualized structural changes induced by PDT. Results: This research explores the potential of T1 and T2 relaxation times as indicators of PDT efficacy, while Gadovist helped provide evidence of 1O2 diffusion within the samples. Conclusions: Considering advancements in modern treatment, PDT may offer a novel approach for targeting atherosclerosis.
- 25 July 2025
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 5 (3) , 32
Open AccessMagnetic Resonance Imaging Evaluation of Photodynamic Therapy with Indocyanine Green in Atherosclerosis Plaques Before and After Gadovist Administration
Background: Singlet oxygen (1O2) generation in biological samples remains a significant challenge. Studying the mechanism of 1O2 action during photodynamic therapy (PDT) in atherosclerotic plaques in vitro represents an innovative cardiological approach. Atherosclerosis, a chronic and progressive disease, is characterized by plaque buildup inside arterial walls. Objectives: This study focused on the use of spin–lattice (T1) and spin–spin (T2) relaxation times measured by Magnetic Resonance Imaging (MRI) before and after the administration of indocyanine green-mediated PDT (ICG-PDT). Methods: To enhance visualization of morphological changes in atherosclerotic plaques, the clinically approved MRI contrast agent Gadovist was utilized. A total of 12 atherosclerotic plaque samples were collected from six patients undergoing endarterectomy. The generation of 1O2 in these plaques was assessed using quantitative MRI measurements and microscopic imaging, which visualized structural changes induced by PDT. Results: This research explores the potential of T1 and T2 relaxation times as indicators of PDT efficacy, while Gadovist helped provide evidence of 1O2 diffusion within the samples. Conclusions: Considering advancements in modern treatment, PDT may offer a novel approach for targeting atherosclerosis.
- Open Access
- 7 February 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 399
Visualization of Atherosclerotic Plaques Paired with Joheksol 350 (Omnipaque)
Background: Cardiovascular disease is one of the leading causes of death around the globe. Atherosclerosis, a chronic inflammatory blood vessel disease that takes years to develop, is its primary cause. Instability and further plaque buildup are caused by chronic inflammation, which creates the conditions for possible rupture. The visualization of arterial lesions in situ can enhance understanding of atherosclerosis progression and potentially improve experimental therapies. Conventional histology methods for assessing atherosclerotic lesions are robust but are destructive and may prevent further tissue analysis. Objectives: The objective of the current study was to evaluate a novel, nondestructive method for the visualization and characterization of atherosclerotic lesions. Methods and Results: Thus, we tested the hypothesis that MRI paired with an iodine-based radiopaque stain would effectively characterize atherosclerotic plaques in a manner comparable to routine histology while maintaining sample integrity and providing whole-volume data.
- 7 February 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 399
Open AccessVisualization of Atherosclerotic Plaques Paired with Joheksol 350 (Omnipaque)
Background: Cardiovascular disease is one of the leading causes of death around the globe. Atherosclerosis, a chronic inflammatory blood vessel disease that takes years to develop, is its primary cause. Instability and further plaque buildup are caused by chronic inflammation, which creates the conditions for possible rupture. The visualization of arterial lesions in situ can enhance understanding of atherosclerosis progression and potentially improve experimental therapies. Conventional histology methods for assessing atherosclerotic lesions are robust but are destructive and may prevent further tissue analysis. Objectives: The objective of the current study was to evaluate a novel, nondestructive method for the visualization and characterization of atherosclerotic lesions. Methods and Results: Thus, we tested the hypothesis that MRI paired with an iodine-based radiopaque stain would effectively characterize atherosclerotic plaques in a manner comparable to routine histology while maintaining sample integrity and providing whole-volume data.
- Open Access
- 29 August 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (9) , 9503-9522
Biomarkers That Seem to Have the Greatest Impact on Promoting the Formation of Atherosclerotic Plaque in Current Scientific Research
Atherosclerosis is a chronic inflammatory disease that causes degenerative and productive changes in the arteries. The resulting atherosclerotic plaques restrict the vessel lumen, causing blood flow disturbances. Plaques are formed mainly in large- and medium-sized arteries, usually at bends and forks where there is turbulence in blood flow. Depending on their location, they can lead to various disease states such as myocardial infarction, stroke, renal failure, peripheral vascular diseases, or sudden cardiac death. In this work, we reviewed the literature on the early detection of atherosclerosis markers in the application of photodynamic therapy to atherosclerosis-related diseases. Herein, we described the roles of C-reactive protein, insulin, osteopontin, osteoprotegerin, copeptin, the TGF-β cytokine family, and the amino acid homocysteine. Also, we discuss the role of microelements such as iron, copper, zinc, and Vitamin D in promoting the formation of atherosclerotic plaque. Dysregulation of the administered compounds is associated with an increased risk of atherosclerosis. Additionally, taking into account the pathophysiology of atherosclerotic plaque formation, we believe that maintaining homeostasis in the range of biomarkers mentioned in this article is crucial for slowing down the process of atherosclerotic plaque development and the stability of plaque that is already formed.
- 29 August 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (9) , 9503-9522
Open AccessBiomarkers That Seem to Have the Greatest Impact on Promoting the Formation of Atherosclerotic Plaque in Current Scientific Research
Atherosclerosis is a chronic inflammatory disease that causes degenerative and productive changes in the arteries. The resulting atherosclerotic plaques restrict the vessel lumen, causing blood flow disturbances. Plaques are formed mainly in large- and medium-sized arteries, usually at bends and forks where there is turbulence in blood flow. Depending on their location, they can lead to various disease states such as myocardial infarction, stroke, renal failure, peripheral vascular diseases, or sudden cardiac death. In this work, we reviewed the literature on the early detection of atherosclerosis markers in the application of photodynamic therapy to atherosclerosis-related diseases. Herein, we described the roles of C-reactive protein, insulin, osteopontin, osteoprotegerin, copeptin, the TGF-β cytokine family, and the amino acid homocysteine. Also, we discuss the role of microelements such as iron, copper, zinc, and Vitamin D in promoting the formation of atherosclerotic plaque. Dysregulation of the administered compounds is associated with an increased risk of atherosclerosis. Additionally, taking into account the pathophysiology of atherosclerotic plaque formation, we believe that maintaining homeostasis in the range of biomarkers mentioned in this article is crucial for slowing down the process of atherosclerotic plaque development and the stability of plaque that is already formed.
- Open Access
- 5 August 2024
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 4 (3) , 505-518
Photodynamic Therapy of Atherosclerotic Plaque Monitored by T1 and T2 Relaxation Times of Magnetic Resonance Imaging
Atherosclerosis, marked by plaque accumulation within arteries, results from lipid dysregulation, inflammation, and vascular remodeling. Plaque composition, including lipid-rich cores and fibrous caps, determines stability and vulnerability. Photodynamic therapy (PDT) has emerged as a promising treatment, leveraging photosensitizers to induce localized cytotoxicity upon light activation. PDT targets plaque components selectively, reducing burden and inflammation. Challenges remain in optimizing PDT parameters and translating preclinical success to clinical efficacy. Nonetheless, PDT offers a minimally invasive strategy for atherosclerosis management, promising personalized interventions for cardiovascular health. The objective of the current study was to present the findings from quantitative non-contrast MRI of atherosclerosis post-PDT by assessing relaxation times. The study aimed to utilize and optimize a 1.5T MRI system. Clinical scanners were used for MRI examinations. The research involved analyzing T1 and T2 relaxation times. Following treatment of the samples with Rose Bengal and exposure to pure oxygen, PDT irradiation was administered. The results indicated that the therapy impacted the crus, evidenced by a significant decrease in relaxation times in the MRI data.
- 5 August 2024
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 4 (3) , 505-518
Open AccessPhotodynamic Therapy of Atherosclerotic Plaque Monitored by T1 and T2 Relaxation Times of Magnetic Resonance Imaging
Atherosclerosis, marked by plaque accumulation within arteries, results from lipid dysregulation, inflammation, and vascular remodeling. Plaque composition, including lipid-rich cores and fibrous caps, determines stability and vulnerability. Photodynamic therapy (PDT) has emerged as a promising treatment, leveraging photosensitizers to induce localized cytotoxicity upon light activation. PDT targets plaque components selectively, reducing burden and inflammation. Challenges remain in optimizing PDT parameters and translating preclinical success to clinical efficacy. Nonetheless, PDT offers a minimally invasive strategy for atherosclerosis management, promising personalized interventions for cardiovascular health. The objective of the current study was to present the findings from quantitative non-contrast MRI of atherosclerosis post-PDT by assessing relaxation times. The study aimed to utilize and optimize a 1.5T MRI system. Clinical scanners were used for MRI examinations. The research involved analyzing T1 and T2 relaxation times. Following treatment of the samples with Rose Bengal and exposure to pure oxygen, PDT irradiation was administered. The results indicated that the therapy impacted the crus, evidenced by a significant decrease in relaxation times in the MRI data.